Page 49 - Policy Analysis News Today

When the COVID-19 pandemic swept the country in early 2020 and emptied doctors offices nationwide, telemedicine was suddenly thrust into the spotlight. Patients and their physicians turned to virtual visits by video or phone rather than risk meeting face-to-face.

The federal government has lifted restrictions on one of the most effective opioid addiction treatment medications. The change sets up a “truth serum moment”: Will mainstream doctors and nurses now

Bombing a prelim seems so easy to say and accept, but once you’re in that situation, it can feel like the end of the world, especially to students who are ambitious and high achievers. It feels harder for me to accept this reality because I caged myself in the notion that I shouldn’t find any of my classes difficult, especially because I am in a humanities-based major. As a student studying Policy Analysis and Management, I’ve always compared my workload to my pre-medical or engineering fr...

Support from physicians and recent moves by the provinces and territories suggest that national medical licensure in Canada could finally become a reality.

McROBERTS, Ky. — Like most coal miners’ loved ones, Liz Williams has endured many days and nights of worry.

Diego never imagined he’d carry a gun. Not as a child, when shots were fired outside his Chicago-area home. Not at age 12, when one of his friends was gunned

During a four-hour hearing last week that could eliminate nationwide access to a common and widely used abortion pill, federal Judge Matthew Kacsmaryk, of the Northern District of Texas, signaled

A state law says giving false information to patients about covid-19 constitutes unprofessional conduct for which regulators can discipline doctors. Vaccine skeptics, including Robert F. Kennedy Jr., join civil liberties groups and others.

For some, the war in Ukraine is not only a struggle against an invasion but also a battle against one’s inner darkness, ...

Gov. Gavin Newsom, who blasted pharmaceutical companies for gouging Californians, is moving ahead with state-branded insulin. He’s also eyeing other generic drugs.